India, Oct. 19 -- IMU Biosciences, a biotechnology company focused on immune profiling and AI-driven analysis, announced a collaboration with UK Biobank to generate high-resolution immune profiling data from an initial cohort of 80,000 blood samples.
The project will combine IMU's High Definition Immunology platform with technologies from Waters Corporation (WAT) and Ultima Genomics to generate more than 100 million immune data points per sample.
The study aims to integrate immune-cell profiling, transcriptomic analysis and AI-based computational methods to examine how immune variation relates to disease risk, progression, treatment response and long-term health outcomes.
The collaboration will add a detailed immune profiling layer to UK...